# Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.

> **NCT06013540** · PHASE2 · UNKNOWN · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 122 (actual)

## Conditions studied

- Melasma

## Interventions

- **COMBINATION_PRODUCT:** TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C)
- **COMBINATION_PRODUCT:** Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%)

## Key facts

- **NCT ID:** NCT06013540
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-08-30
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06013540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06013540, "Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06013540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*